CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Xyzal Oral Product +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03673384
NCT03673384N/ACompleted

Effect of Health Promotion on Allergic Rhinitis by Infrared-C Ray Irradiation

Nanhua University·interventional·Posted Sep 17, 2018·Updated Sep 17, 2018

In Brief

A clinical study evaluating infrared-C ray irradiation, eye mask, and 2 other interventions for Allergic Rhinitis. Completed, enrolled 50 participants.

Detailed Summary

Allergic rhinitis is one of the chronic illnesses. At present, the major treatments for allergic rhinitis are avoiding allergens, medical treatment and surgery. However, inadequate effects, and possible side effects of these treatments are still problems to these patients. Therefore, to find an effective non-medical and non-surgical treatment will be of great help in treating patients with allergic rhinitis. Infrared-C (far-infrared) ray irradiation is able to promote normal operation of autonomic nervous system, to improve blood circulation and thereby assumed to relieve discomfort symptoms of patients with vascular, specific or non-specific allergic rhinitis. Consequently, infrared-C ray irradiation is expected to be effective for the treatment of allergic rhinitis. The investigators aimed to probe the adjunct effects of infrared-C ray irradiation in terms of infrared-C hot compress in improving allergy symptoms like sneezing, rhinorrhea, nasal obstruction, nose and conjunctiva itching during a medical treatment for patients with allergic rhinitis. Moreover, the impact of infrared-C irradiation on health and life quality enhancement will also be studied.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 17, 2018
Enrollment StartMar 2, 2015
Primary CompletionJul 30, 2017
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 7.8 years ago

Interventions

infrared-C ray irradiationdevice

Infrared-C irradiation by hot compress with a powered heating compress

eye maskdevice

infrared-C irradiation by hot compress with a powered heating eye mask

Xyzal Oral Productdrug

used to relieve allergy symptoms, It works by blocking histamine that body secretes during an allergic reaction.

Fluticasone Furoatedrug

used to treat seasonal and perennial allergic rhinitis. It also helps to reduce the symptoms of seasonal allergic rhinitis.